Cardiovascular risk factors play greater role in adverse outcomes in thymic cancer patients
Thymic cancer, a rare type of cancer that has brought patients to Indiana University Health in recent years for treatment, has become the subject of further study between investigators from the Krannert Cardiovascular Research Center and the Melvin and Bren Simon Comprehensive Cancer Center at Indiana University School of Medicine, and collaborators at Regenstrief Institute. The researchers wanted to explore cardiovascular risk factors for adverse outcomes among people with and without thymic cancer. Results of their study was published in Frontiers.
Urologic oncologist turns to IU mentors for his own testicular cancer treatment
Sean Kern, MD, an IU-trained urologic oncologist and founding director of the military’s testicular cancer enterprise, was diagnosed with the very disease he specializes in
From lab to market: Discoveries in Kelley Lab lead to new therapies for multiple diseases
Over the last 30 years, Mark R. Kelley has disclosed 61 inventions, been awarded 19 patents and launched a pharmaceutical startup. Now he's helping other
Duncan leads quest to end health disparities in lung cancer
Francesca Duncan, MD, is determined to end disparities in the diagnosis and treatment of lung cancer—the leading cause of cancer deaths in the United States.
Mutations, mammograms and MRIs, oh my! How I took charge of my breast health with increased screenings, and when you should do the same
Christina Griffiths is a media relations specialist for Indiana University School of Medicine and has worked with the office of strategic communications for five years.
Doyle Publishes in Health Affairs on Personal Experience with Decision Aids
Tom Doyle, PhD, a postdoctoral fellow from the Center for Bioethics, reflects on his recent publication in Health Affairs on his personal experience with Hodgkin's
IU researchers find link between obesity and blood cancer
Indiana University School of Medicine researchers found a strong association between obesity and clonal hematopoiesis of indeterminate potential (CHIP), a condition where blood cells accumulate
Researchers uncover new drug combination to treat rare pediatric cancer called JMML
IU School of Medicine researchers have identified a promising new combination of drugs for treating a rare form of childhood blood cancer called JMML.
Pediatric researchers receive two new grants to support work based on Tyler Trent's tumor cells
Two new grants supporting osteosarcoma research have been funded at IU School of Medicine, building on work that has been previously established based on Tyler
Francesca Duncan, MD on Health Care Disparities and Medical Education Surrounding Racism
Francesca Duncan, MD research interests include health disparities in lung cancer. Her work includes an exciting new field coined "social epigenomics" which has emerged as
Researchers secure grant to better understand barriers to cancer survivorship for adolescents and young adults
A team of researchers at IU School of Medicine have received $100,000 in pilot funding to research how best to deliver cancer survivorship healthcare to